Astellas Pharma Inc (ALPMF) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astellas Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.757 -- 00:00:03.749 Thank you very much for your joining with us. 00:00:03.749 -- 00:00:09.905 This is the FY25, the third quarter earnings goal. 00:00:13.497 -- 00:00:18.443 My name is Kato. I'm serving as the moderator for today. 00:00:18.443 -- 00:00:23.068 I am chief communications and IR officer. 00:00:23.068 -- 00:00:27.714 Today, following our presentation, we will proceed to the Q&A session. 00:00:27.714 -- 00:00:33.741 The presentation will follow the presentation materials available on our website. 00:00:33.741 -- 00:00:39.147 The session, including Q&A, will be conducted with simultaneous interpretation 00:00:39.147 -- 00:00:44.096 in Japanese and English, please note that we cannot guarantee the accuracy of the simultaneous 00:00:44.096 -- 00:00:46.096 interpretation. 00:00:47.742 -- 00:00:54.453 You may select your language from the menu on the Zoom webinar screen. 00:00:54.453 -- 00:00:59.622 If you choose the original language, you can view the presentation in the original audio 00:00:59.622 -- 00:01:02.784 without simultaneous interpretation. 00:01:05.050 -- 00:01:07.050 This 00:01:07.073 -- 00:01:12.081 is some notes for today's presentation. 00:01:12.081 -- 00:01:16.648 This material presentation and answers and statement by representatives for the company 00:01:16.648 -- 00:01:21.676 in the QA session includes forward-looking statements based on assumptions, benefits, 00:01:21.676 -- 00:01:26.344 or beliefs, rather, in light of the information currently available to management and 00:01:26.344 -- 00:01:30.928 subject to significant risks and uncertainties. 00:01:31.375 -- 00:01:34.560 Actual financial results may differ materially, 00:01:34.560 -- 00:01:37.782 depending on a number of factors. 00:01:40.970 -- 00:01:45.737 They conta...